The Intersection of Pharmacy and Financial Incentives

This chapter explores the companies selling compounded drugs, especially in relation to off-brand Ozempic. It highlights niche practices like double nomics and emphasizes the importance of bundling insurance and technology in advancing business strategies.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app